Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Pediatric LSC3 (pLSC3) Score Derived from DNMT3B-CD34-GPR56 As a Prognostic Tool to Predict AML Patient Outcome: Results from Two Independent Pediatric AML Cohorts

Abdelrahman H Elsayed, MSc, Huiyun Wu, PhD, Xueyuan Cao, PhD, Susana C. Raimondi, PhD, James R. Downing, MD, Raul Ribeiro, MD, Tanja A. Gruber, MD PhD, Jeffrey Rubnitz, MD PhD, Stanley Pounds, PhD, Jatinder K Lamba, PhD

Blood (2018) 132 (Supplement 1): 290.

https://doi.org/10.1182/blood-2018-99-116462

Published: 2018

Journal Articles

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Michael Ellison, PhD, Natalie Briones, MS, Angelina Baroffio, John Murphy, Katherine Gowan, Bridget Sanford, Kenneth L. Jones, PhD, Daniel R. Ambruso, MD

Blood (2018) 132 (Supplement 1): 2398.

https://doi.org/10.1182/blood-2018-99-115314

Published: 2018

Journal Articles

Crosstalk between the IGF1 and CXCL12 Pathways Defines Objective Responses to the Farnesyl Transferase Inhibitor Tipifarnib in AML and PTCL Patients

Antonio Gualberto, PhD MD, Catherine Scholz, PharmD, Vishnu Mishra, PhD, Matthew R Janes, PhD, Linda Kessler, BA

Blood (2018) 132 (Supplement 1): 5349.

https://doi.org/10.1182/blood-2018-99-116969

Published: 2018

Journal Articles

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

Konstantinos Christofyllakis, MD, Frank Neumann, PhD, Stephan Stilgenbauer, Dominic Kaddu-Mulindwa, MD, Evi Regitz, Moritz Bewarder, MD, Andreas Keller, PhD MSc, Jörg Thomas Bittenbring, MD

Blood (2018) 132 (Supplement 1): 3696.

https://doi.org/10.1182/blood-2018-99-111817

Published: 2018

Journal Articles

The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Antonio Gualberto, PhD MD, Catherine Scholz, PharmD, Matthew R Janes, PhD, Linda Kessler, BA, Azra Raza, MD

Blood (2017) 130 (Supplement 1): 3957.

https://doi.org/10.1182/blood.V130.Suppl_1.3957.3957

Published: 2017

Journal Articles

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Chloe Beate Steen, Ellen Leich, June Helen Myklebust, PhD, Sandra Lockmer, Jillian Frances Wise, Björn Engelbrekt Wahlin, Bjørn Østenstad, Knut Liestol, Eva Kimby, Andreas Rosenwald, Erlend Bremertun Smeland, Harald Holte, Ole Christian Lingjærde, Marianne Brodtkorb

Blood (2017) 130 (Supplement 1): 1467.

https://doi.org/10.1182/blood.V130.Suppl_1.1467.1467

Published: 2017

Journal Articles

An Immature Immunophenotype (CD34pos, CD38dim, nTdTdim) on Malignant B-Cell Precursor Blasts at Diagnosis Predicts High Minimal Residual Disease in BCP-ALL

Signe Modvig, MD PhD, Nina Friesgaard Øbro, PhD, Susanne Rosthøj, PhD, Gitte W Jürgensen, MD, Kjeld Schmiegelow, MD DMSc, Hanne Vibeke Marquart, MD PhD

Blood (2016) 128 (22): 1728.

https://doi.org/10.1182/blood.V128.22.1728.1728

Published: 2016

Journal Articles

Transcriptome Analysis Identified Significant Differences in Gene Expression Variability Between WM and IgM-MGUS BM B Cell Clones

Alessandra Trojani, Milena Lodola, Alessandra Tedeschi, Antonino Greco, Barbara Di Camillo, Tiziana Sanavia, Anna Maria Frustaci, Maddalena Mazzucchelli, Chiara Villa, Daniela Boselli, Enrica Morra, MD, Roberto Cairoli, MD

Blood (2016) 128 (22): 5089.

https://doi.org/10.1182/blood.V128.22.5089.5089

Published: 2016

Journal Articles

Acute Monocytic Leukemia Associated Antigen MLAA-34 up-Regulates JAK2/STAT3 Expression and JAK2/STAT3 Enhances MLAA-34 Activation in a Positive Feedback Loop

Bo Lei, Ju Bai, Wanggang Zhang, Aili He, Yinxia Chen, Pengyu Zhang, Lu Qian, Fuling Zhou

Blood (2015) 126 (23): 1393.

https://doi.org/10.1182/blood.V126.23.1393.1393

Published: 2015

Journal Articles

The PI3 Kinase (PI3K) Inhibitor, Buparlisib/BKM120, in B-Cell, T-Cell and Hodgkin Lymphoma Cell Lines: Cell Death Studies and Examination of Genomic Pathway Analyses Via a Systems Biology Approach

Michael E Coyle, MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 1555.

https://doi.org/10.1182/blood.V126.23.1555.1555

Published: 2015

Journal Articles

Subtyping of B-Cell Malignancies By B-Cell Subset Associated Gene Signatures (BAGS), Generated from Human Primary and Secondary Lymphoid Organs.

Julie Støve Bødker, PhD, Alexander Schmitz, Dr. rer. nat., Anders Ellern Bilgrau, PhDstudent, Andreas Rasmussen, M.Sc., Lasse Hjort Jakobsen, PhDstudent, Tarec Christoffer El-Galaly, MD, Hans Erik Johnsen, Karen Dybkær, Professor, Martin Bøgsted, Professor

Blood (2015) 126 (23): 5347.

https://doi.org/10.1182/blood.V126.23.5347.5347

Published: 2015

Journal Articles

Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia

Blood (2015) 126 (23): 250.

https://doi.org/10.1182/blood.V126.23.250.250

Published: 2015

Journal Articles

Co-Expression of NUP98-HOXD13 and Mutant IDH2 Triggers an Early T-Cell Precursor-like Leukemia in Mice

Liat Goldberg, PhD, Rachel M Pierce, Masahiro Onozawa, MD PhD, Robert L Walker, Yeulin J Zhu, Paul S Meltzer, MD PhD, Peter D. Aplan, MD

Blood (2015) 126 (23): 904.

https://doi.org/10.1182/blood.V126.23.904.904

Published: 2015

Journal Articles

ASPP2 Attenuation Is an Early Step in Leukemogenesis Facilitating Acquisition of Mutations

Kerstin M Kampa-Schittenhelm, Dr., MD, Figen Akmut, Barbara Illing, Charles Lopez, Marcus M Schittenhelm, Dr., MD

Blood (2014) 124 (21): 2221.

https://doi.org/10.1182/blood.V124.21.2221.2221

Published: 2014

Journal Articles

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Blood (2014) 124 (21): 2973.

https://doi.org/10.1182/blood.V124.21.2973.2973

Published: 2014

Journal Articles

Hh/IGF-1R/PI3K/Akt/MRP1 Pathway Induce Refractory Acute Myeloid Leukemia and Its Targeting Therpy

Kaikai Huang, Bingjie Ding, MD, Qingxiu Zhong, MD, Xuejie Jiang, MDPhD, Xiaodong Li, MD, Zhixiang Wang, MD, Fan Yi Meng, MD

Blood (2014) 124 (21): 3612.

https://doi.org/10.1182/blood.V124.21.3612.3612

Published: 2014

Journal Articles

Glutamate Receptor Polymorphisms Contribute to Glucocorticoid-Associated Osteonecrosis

Blood (2014) 124 (21): 367.

https://doi.org/10.1182/blood.V124.21.367.367

Published: 2014

Journal Articles

A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Naval Daver, MD, Hagop M. Kantarjian, MD, Deborah A. Thomas, MD, Michael E. Rytting, MD, Farhad Ravandi, MD, Nitin Jain, MD, Jorge E. Cortes, MD, Rebecca Garris, BSc, Mary Ann Richie, RN, Marina Konopleva, MD, PhD, Hongbo Hu, PHD, Jitesh Kawedia, PHD, BS, Kirk Culotta Pharmd, BS, Susan O'Brien, MD, Jordan Basnett, Lianchun Xiao, Xuelin Haung, Linda J. Bendall, BSc, PhD

Blood (2013) 122 (21): 3916.

https://doi.org/10.1182/blood.V122.21.3916.3916

Published: 2013

Journal Articles

Synergistic Effect of Sequential Combination of Decitabine and Idarubicin in Mouse Model of Human Acute Myeloid Leukemia

Hongyan Tong, MD, Kongfei Li, Chen Mei, Chao Hu, Jie Jin, MD

Blood (2012) 120 (21): 1515.

https://doi.org/10.1182/blood.V120.21.1515.1515

Published: 2012

Journal Articles

Attenuation of Apoptosis-Stimulating Protein of p53 2 (ASPP2 or TP53BP2) Associates with High Risk Disease and Therapy Failure in Acute Leukemia

Marcus M Schittenhelm, Dr., MD, Charles D Lopez, MD, PhD, Lothar Kanz, MD, Kerstin M Kampa-Schittenhelm, Dr., MD

Blood (2012) 120 (21): 1416.

https://doi.org/10.1182/blood.V120.21.1416.1416

Published: 2012

NARROW

Pediatric LSC3 (pLSC3) Score Derived from DNMT3B-CD34-GPR56 As a Prognostic Tool to Predict AML Patient Outcome: Results from Two Independent Pediatric AML Cohorts

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Crosstalk between the IGF1 and CXCL12 Pathways Defines Objective Responses to the Farnesyl Transferase Inhibitor Tipifarnib in AML and PTCL Patients

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

An Immature Immunophenotype (CD34pos, CD38dim, nTdTdim) on Malignant B-Cell Precursor Blasts at Diagnosis Predicts High Minimal Residual Disease in BCP-ALL

Transcriptome Analysis Identified Significant Differences in Gene Expression Variability Between WM and IgM-MGUS BM B Cell Clones

Acute Monocytic Leukemia Associated Antigen MLAA-34 up-Regulates JAK2/STAT3 Expression and JAK2/STAT3 Enhances MLAA-34 Activation in a Positive Feedback Loop

The PI3 Kinase (PI3K) Inhibitor, Buparlisib/BKM120, in B-Cell, T-Cell and Hodgkin Lymphoma Cell Lines: Cell Death Studies and Examination of Genomic Pathway Analyses Via a Systems Biology Approach

Subtyping of B-Cell Malignancies By B-Cell Subset Associated Gene Signatures (BAGS), Generated from Human Primary and Secondary Lymphoid Organs.

Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia

Co-Expression of NUP98-HOXD13 and Mutant IDH2 Triggers an Early T-Cell Precursor-like Leukemia in Mice

ASPP2 Attenuation Is an Early Step in Leukemogenesis Facilitating Acquisition of Mutations

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Hh/IGF-1R/PI3K/Akt/MRP1 Pathway Induce Refractory Acute Myeloid Leukemia and Its Targeting Therpy

Glutamate Receptor Polymorphisms Contribute to Glucocorticoid-Associated Osteonecrosis

A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Synergistic Effect of Sequential Combination of Decitabine and Idarubicin in Mouse Model of Human Acute Myeloid Leukemia

Attenuation of Apoptosis-Stimulating Protein of p53 2 (ASPP2 or TP53BP2) Associates with High Risk Disease and Therapy Failure in Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only